A. S. Zhuravlev

Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression

E. Imyanitov, E. Preobrazhenskaya, A. Iyevleva, 2016, Oncology Research and Treatment.

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients

A. Sokolenko, E. Imyanitov, E. Preobrazhenskaya, 2018, Clinical Drug Investigation.

Pseudomyxoma Peritonei as a First Manifestation of KRAS-Mutated Urachal Mucinous Cystadenocarcinoma of the Bladder: A Case Report

V. A. Kheinshtein, K. Shelekhova, D. Krylova, 2017, International Journal of Surgical Pathology.